RCKT (RCKT) Stock Price & Analysis
RCKT (RCKT) rose 0.00% to USD 3.19 as of July 25, 2026 at 04:32 UTC, according to Nexqual real-time market data.
RCKT last closed at USD 3.19; the session ranged USD 3.17–3.31 on volume of 1,139,895 shares. Market capitalization is —, with a 52-week range of USD 2.53–5.45 (NGM). Source: Nexqual, July 25, 2026 at 04:32 UTC.
Key Statistics (as of July 25, 2026 at 04:32 UTC)
| Price | USD 3.19 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 3.19 |
| Open | USD 3.19 |
| Day Range | USD 3.17 – 3.31 |
| 52-Week Range | USD 2.53 – 5.45 |
| Volume | 1,139,895 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (RCKT)
Nexqual's technical model rates RCKT "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 04:32 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 42.98 (neutral) |
| vs SMA50 | Below (USD 3.26) |
| MACD | -0.01 (negative) |
From RCKT's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ARVN | Arvinas, Inc. | USD 8.03 | ▼ 2.78% |
| RGNX | REGENXBIO Inc. | USD 9.73 | ▼ 4.61% |
| REPL | Replimune Group, Inc. | USD 9.7 | ▼ 9.77% |
| DNLI | Denali Therapeutics Inc. | USD 23.11 | ▼ 2.24% |
| KURA | Kura Oncology, Inc. | USD 10.39 | ▼ 1.42% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:32 UTC. This page is informational and not investment advice.